New England Journal of Medicine: The Upcoming U.S. Health Care Cost Debate — The Public’s Views


June 27, 2019
N Engl J Med 2019; 380:2487-2492
DOI: 10.1056/NEJMp1905710

  • Robert J. Blendon, Sc.D.,  John M. Benson, M.A., and Caitlin L. McMurtry, S.M.

U.S. health care costs — and not merely prescription-drug prices — have risen to the top of the national agenda. More than two thirds (69%) of the U.S. public has said that reducing these costs should be a top priority for President Donald Trump and Congress in 2019, ranking it behind only strengthening the economy (70%) on a list of 18 possible priorities (Pew, 2019) (see table). Given a list of 13 possible health-specific priorities, about 9 in 10 Americans said both prescription-drug prices (92%) and lowering the overall cost of health care (88%) were extremely important (Politico–HSPH, December 2018).

PLEASE READ THE FULL ARTICLE ON NEJM.ORG